Neogenomics Inc.

NASDAQ:NEO   4:00:00 PM EDT
11.21
+1.09 (+10.77%)
7:50:18 PM EDT: $11.20 -0.01 (-0.09%)
Earnings Announcements

Neogenomics Quarterly Consolidated Revenue Rises 6%

Published: 11/08/2022 12:20 GMT
Neogenomics Inc. (NEO) - Qtrly Consolidated Revenue Increased 6% to $129 Million.
Qtrly Loss per Share $0.30.
Qtrly Adjusted Loss per Share $0.14.
Q3 Earnings per Share View $-0.21, Revenue View $121.5 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $129.97 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $126.83 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.